The ETERNAL project's penultimate General Assembly Meeting, struck a positive and industrious note as the project partners gear up their activities and focus upon scale-up and adoption of Green Pharma innovation across the project’s six industrial case studies and supporting research into enhanced Environmental Risk Assessment and Digitalisation of Pharma processes and workflows.